Tumour lysis syndrome with acute renal failure during imatinib therapy.
Ali
Ridvan
R
Ozkalemkas
Fahir
F
Ozkan
Atilla
A
Ozcelik
Tulay
T
Ozkocaman
Vildan
V
Akdag
Ibrahim
I
Ozan
Ulku
U
Tunali
Ahmet
A
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D007680:Kidney Neoplasms / Q000139:chemically induced* / Q000188:drug therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000009:adverse effects*; D015275:Tumor Lysis Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases